ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC57.10

C57.10

Billable

Malignant neoplasm of unspecified broad ligament

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C57.10 is a billable code used to indicate a diagnosis of malignant neoplasm of unspecified broad ligament.

Key Diagnostic Point:

C57.10 refers to a malignant neoplasm located in the broad ligament, which is a peritoneal fold that extends from the sides of the uterus to the pelvic walls. This neoplasm is classified as malignant, indicating that it has the potential to invade surrounding tissues and metastasize to other parts of the body. The broad ligament supports the uterus, ovaries, and fallopian tubes, and tumors in this area can arise from various cell types, including mesenchymal and epithelial cells. Symptoms may include abdominal pain, abnormal bleeding, or a palpable mass. Diagnosis typically involves imaging studies such as ultrasound or MRI, and histopathological examination following biopsy. Staging of the tumor is crucial for determining the prognosis and treatment options, which may include surgery, chemotherapy, or radiation therapy. The CA-125 blood test may be utilized as a tumor marker, particularly in cases of ovarian cancer, but its role in broad ligament tumors is less defined. Accurate coding requires comprehensive documentation of the tumor's characteristics, staging, and treatment plan.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variability in tumor presentation and symptoms
  • Need for precise staging information
  • Differentiation from other gynecologic malignancies
  • Documentation of treatment modalities

Audit Risk Factors

  • Inadequate documentation of tumor characteristics
  • Failure to document staging details
  • Misclassification with benign conditions
  • Lack of clarity in treatment plans

Specialty Focus

Medical Specialties

Gynecologic Oncology

Documentation Requirements

Detailed pathology reports, imaging studies, and treatment plans are essential for accurate coding.

Common Clinical Scenarios

Diagnosis and management of malignant neoplasms in the broad ligament, staging assessments, and treatment planning.

Billing Considerations

Coders must be familiar with the nuances of gynecologic malignancies and the importance of staging in treatment decisions.

Radiology

Documentation Requirements

Imaging reports must clearly indicate the presence of neoplasms and any relevant findings.

Common Clinical Scenarios

Imaging studies for suspected broad ligament tumors and follow-up imaging post-treatment.

Billing Considerations

Radiologists should provide comprehensive reports that include tumor size, location, and any signs of metastasis.

Coding Guidelines

Inclusion Criteria

Use C57.10 When
  • According to ICD
  • 10 coding guidelines, C57
  • 10 should be used when the specific site of the malignant neoplasm in the broad ligament is not documented
  • Coders should ensure that all relevant clinical information is captured to support the diagnosis and treatment

Exclusion Criteria

Do NOT use C57.10 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

58150CPT Code

Total abdominal hysterectomy

Clinical Scenario

Used when a patient undergoes surgery for a malignant neoplasm of the broad ligament.

Documentation Requirements

Operative reports must detail the procedure and findings.

Specialty Considerations

Gynecologic oncologists should ensure that all surgical findings are documented to support coding.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of gynecologic malignancies, including C57.10, which enhances data accuracy and improves patient care through better tracking of treatment outcomes.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of gynecologic malignancies, including C57.10, which enhances data accuracy and improves patient care through better tracking of treatment outcomes.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of gynecologic malignancies, including C57.10, which enhances data accuracy and improves patient care through better tracking of treatment outcomes.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What is the significance of staging in C57.10?

Staging is crucial for determining the extent of the disease, guiding treatment options, and predicting patient outcomes. Accurate staging requires thorough documentation of tumor size, lymph node involvement, and metastasis.